sars-cov2_vaccine

SARS-COV2 vaccine

SARS-COV2 vaccine

Acceptance of case reports in the European Journal of Neurology is extremely limited, and only reports that make a major clinicopathological or educational contribution or suggest a significant change of diagnosis or therapy will be accepted. We have decided that we will not publish single cases (or small descriptive series) of neurological disorders occurring after vaccination against SARS-COV2 infection.

  • sars-cov2_vaccine.txt
  • Last modified: 2021/05/10 09:15
  • by administrador